These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 2109591)
1. Immunosuppressive effect of misoprostol: a new synthetic prostaglandin E1 analogue. Wiederkehr JC; Dumble L; Pollak R; Moran M Aust N Z J Surg; 1990 Feb; 60(2):121-4. PubMed ID: 2109591 [TBL] [Abstract][Full Text] [Related]
2. Misoprostol with cyclosporin A prolongs corneal allograft survival in an animal model. Olsen TW; Gothard TW; Holland EJ Cornea; 1996 Jan; 15(1):76-81. PubMed ID: 8907385 [TBL] [Abstract][Full Text] [Related]
3. The effect of the prostaglandin analogues misoprostil and enisoprost on the synergy between donor-specific transfusion and cyclosporine in allograft survival. Cofer BR; Davies CB; Alexander JW; Tchervenkov JI Transplantation; 1992 Nov; 54(5):941-3. PubMed ID: 1440866 [No Abstract] [Full Text] [Related]
4. Effect of a PGE-1 analogue on the survival of cardiac transplant rats. Gracida Juárez C; Mechor Ortíz JL; Mozes MF Arch Med Res; 1992; 23(1):55-8. PubMed ID: 1308792 [TBL] [Abstract][Full Text] [Related]
5. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767 [TBL] [Abstract][Full Text] [Related]
6. Gramicidin as a potential immunosuppressant for organ transplantation: suppression of human lymphocyte blastogenesis in vitro and prolongation of heart allograft survival in the rat. Hirano T; Oka K; Tamaki T J Pharmacol Exp Ther; 1995 Apr; 273(1):223-9. PubMed ID: 7536243 [TBL] [Abstract][Full Text] [Related]
7. Prolongation of rat heart allograft survival using cyclosporine and enisoprost, a prostaglandin E1 analog. Fabrega AJ; Blanchard J; Rivas PA; Moran SM; Pollak R Transplantation; 1992 Jun; 53(6):1363-4. PubMed ID: 1604492 [No Abstract] [Full Text] [Related]
8. C. sinensis ablates allograft vasculopathy when used as an adjuvant therapy with cyclosporin A. Jordan JL; Hirsch GM; Lee TD Transpl Immunol; 2008 Jul; 19(3-4):159-66. PubMed ID: 18619544 [TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive effects of leflunomide in a cardiac allograft model. Williams JW; Xiao F; Foster PF; Chong A; Sharma S; Bartlett R; Sankary HN Transplant Proc; 1993 Feb; 25(1 Pt 1):745-6. PubMed ID: 8438465 [No Abstract] [Full Text] [Related]
11. Statins induce immunosuppressive effect on heterotopic limb allografts in rat through inhibiting T cell activation and proliferation. Nie C; Yang D; Liu G; Dong D; Ma Z; Fu H; Zhao Z; Sun Z Eur J Pharmacol; 2009 Jan; 602(1):168-75. PubMed ID: 19041862 [TBL] [Abstract][Full Text] [Related]
12. Phenolic nortriterpene demethylzeylasteral: a new immunosuppressive component of Tripterygium Wilfordii Hook f. Tamaki T; Kawamura A; Komatsu Y; Kawamura H; Maruyama H; Morota T Transplant Proc; 1996 Jun; 28(3):1379-80. PubMed ID: 8658703 [No Abstract] [Full Text] [Related]
13. Sirolimus-mediated prolongation of rat cardiac allograft survival is enhanced by beta1 integrin very late antigen-4 blockade. Vu MD; Qi S; Sehgal SN; Chen H; Kennedy JD Transplant Proc; 2005; 37(1):162-3. PubMed ID: 15808581 [TBL] [Abstract][Full Text] [Related]
14. Combination therapy with Brequinar sodium and cyclosporine synergistically prolongs hamster-to-rat cardia xenograft survival. Cosenza CA; Cramer DV; Tuso PJ; Chapman FA; Wang HK; Makowka L J Heart Lung Transplant; 1994; 13(3):489-97. PubMed ID: 8061026 [TBL] [Abstract][Full Text] [Related]
15. Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine. Williams JW; Xiao F; Foster P; Clardy C; McChesney L; Sankary H; Chong AS Transplantation; 1994 Apr; 57(8):1223-31. PubMed ID: 8178350 [TBL] [Abstract][Full Text] [Related]
16. Effect of streptavidin on cardiac allograft prolongation is due to host T-Cell suppression. Witkowski P; Fawwaz RA; Jin MX; DePaz HA; Oluwole OO; Hardy MA; Oluwole SF Transplant Proc; 2005; 37(1):116-8. PubMed ID: 15808566 [TBL] [Abstract][Full Text] [Related]
17. A reduction in accelerated graft coronary disease and an improvement in cardiac allograft survival using low molecular weight heparin in combination with cyclosporine. Aziz S; Tada Y; Gordon D; McDonald TO; Fareed J; Verrier ED J Heart Lung Transplant; 1993; 12(4):634-43. PubMed ID: 8396435 [TBL] [Abstract][Full Text] [Related]
18. Didemnin B prolongs rat heart allograft survival. Stevens DW; Jensen RM; Stevens LE Transplant Proc; 1989 Feb; 21(1 Pt 1):1139-40. PubMed ID: 2650080 [No Abstract] [Full Text] [Related]
19. Combined treatment of glatiramer acetate and low doses of immunosuppressive drugs is effective in the prevention of graft rejection. Aharoni R; Yussim A; Sela M; Arnon R Int Immunopharmacol; 2005 Jan; 5(1):23-32. PubMed ID: 15589456 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of acute rejection after skin or cardiac transplantation by administration of donor antigens in the rat. Shirouzu Y; Hikida S; Tanigawa H; Shirouzu K Surg Today; 2004; 34(4):341-8. PubMed ID: 15052450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]